BIOA
BIOA
NASDAQ · Pharmaceuticals

Bioage Labs Inc

$22.10
-0.22 (-0.99%)
As of Jun 24, 2:16 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 3 20%
Sell 0 0%
Price Target
Analyst Price Target -40.5% upside
Low Target $9.99
Average Target $13.14
High Target $19.07
Current Price $22.10
Current
$22.10
Target
$13.14
$9.99 $13.14 avg $19.07
Scenario Analysis
Bear Case
$9.99
-54.8%
Low target
Base Case
$13.14
-40.5%
Avg target
Bull Case
$19.07
+-13.7%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$24.00
-7.9% from high
52-Week Low
$4.07
+443.7% from low
Target vs 52W High
$13.14
-45.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%